US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer

Jan, 2020

Citations per year

0 Citations
Abstract:
Prostate Cancer (PCa) is one of the most prevalent cancers worldwide. Early and accurate diagnosis of PCa is crucial for effective and successful treatment. Our project aims at developing a unique, highly performing flexible geometry multi-modality imaging system for diagnosis and staging of PCa. The imager will have the form of an endorectal probe combining high-resolution (0.1 mm) ultrasound (US) with a very high-resolution Positron Emission Tomography (PET) probe (1 mm spatial resolution) with exceptional Time-of-Flight (TOF) capability (100 ps FWHM targeted) compatible with Magnetic Resonance Imaging (MRI), in coincidence with a set of external PET panels. While standard multiparametric MRI (mpMR) has drawbacks, diagnosis will be improved significantly by the introduction of PSPMA-PET as well as the simultaneous PET/MR imaging. The system will be capable of morphological visualization instantly and continuously combined with biological and metabolic activity, offering crucial improvement with respect to standard systems (detection of ∼ 2 mm lesions vs. ∼ 6 mm lesions) in spatial resolution, efficiency, signal-to-noise ratio (SNR), scanning time and/or lowering injected dose.
  • [1]
    Eur.Urol.71 618
    • Mottet Nicolas
  • [2]
    Prostate 79 1007
    • Yilmaz B.
  • [3]
    Clin.65 87
    • Torre L. A.
      ,
    • CA Canc. J.
  • [4]
    • Ahmed H. U.
      • Lancet 389 (2017) 815
  • [5]
    BioMed. Res. Int.684127
    • Margolis D.J. A.
  • [6]
    Eur.Urol.68 8
    • Valerio M
  • [7]
    Eur.Urol.70 926
    • Perera M.
  • [8]
    Abdom.Radiol.44 2545
    • Abd Alkhalik Basha Mohammad
  • [9]
    Urol.Oncol.32 e1
    • Dianat S. S.
  • [10]
    Am.J.Roentgenol.,210 1338
    • Taneja S.
  • [11]
    Eur.Urol.67 569
    • Le J. D.
  • [12]
    • Rahbar K.
      • J.Nucl.Med. 57 (2016) 563
  • [13]
    J.Urol.,185 815
    • Rastinehad A. R.
  • [14]
    Eur.Urol.71 896
    • Schouten M. G.
  • [15]
    Eur.Urol.Focus 5 592
    • Sonn G. A.
  • [16]
    • Hicks R. M.
      • Radiology 289 (2018) 730
  • [17]
    Theranostics 7 1770
    • Jilg C. A.
  • [18]
    Nat.Rev.Urol.13 226
    • Maurer T.
  • [19]
    Eur.Urol.70 829
    • Eiber M.
  • [20]
    Clin.Genitourinary Canc.16 245
    • Westenfelder K. M.
  • [21]
    Mol.Imaging 43 1397
    • Mottaghy F. M.
      ,
    • Eur.J.Nucl. M
  • [22]
    Mol.Imaging Biol.20 4Y20
    • Bailey D. L.
  • [23]
    • Herzog Hans Z.
      • Med.Phys. 22 (2012) 281
  • [24]
    Urol.Oncol.: Sem.Orig.Inv.32 39
    • Dianat S. S.
  • [25]
    • Garibaldi F.
      • Eur.Phys.J.Plus 132 (2017) 396